"covaxin"

The Drugs Controller General of India on Sunday gave the permission to Bharat Biotech's Covaxin for use in an emergency situation.

The approval to Covaxin has been questioned by industry experts and some opposition Congress leaders who have expressed concern over the absence of phase 3 trial data

While this vaccine addresses an unmet medical need during this pandemic, our goal is to provide global access to populations that need it the most. Covaxin has generated excellent safety data with robust immune responses

Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV).

This is a major relief for India which has the second highest number of infections in the world, after the US. The Central government plans to vaccinate nearly 30 crore people in the first phase of drive in the next six to eight months.

The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI)

The application will be sent to Drugs Controller General of India (DCGI) V.G. Somani for final approval

Companies to co-develop Covaxin to prevent Covid-19 infection in the US

Trials that began during mid-November are targeted to be done in 26,000 volunteers across multiple sites in India

The project update on Covaxin was presented to the delegates by Dr Krishna Ella, chairman and managing director, Bharat Biotech.

The visit by the heads of foreign missions was organised by the Ministry of External Affairs (MEA) and was part of India's efforts to develop partnerships for the manufacture and delivery of vaccines

In a session titled ‘Transformation of India with a focus on the entrepreneur ecosystem’ Kant said that India has grown as a technology country.

Bharat Biotech stated it is an innovator, vaccine developer and manufacturer and safety of vaccines is its primary objective, followed by efficacy

The 67-year-old minister was given the first shot on November 20.

The 67-year-old is a senior leader of the ruling Bharatiya Janata Party (BJP) and a legislator from Ambala Cantt assembly constituency.

West Bengal Governor Jagdeep Dhankhar said NICED has been chosen as one among two dozen centres in the country for the third phase trial of the indigenously developed coronavirus vaccine.

Hyderabad: The Greater Hyderabad Municipal Corporation election is turning out to be the mother of all polls, for the sheer political heat it has generated and the galaxy of leaders campaigning for the BJP. Saturday, the penultimate day of campaign saw electioneering reach a crescendo with Chief Minister K Chandrashekhar Rao leading the field for […]

BJP leader remained mum on the State govt's demand that vaccine from Hyderabad-based pharma major should first be released to the people of the State

Takes stock of the progress made by the Hyderabad-based company in the trials of Covaxin, jointly developed with ICMR-National Institute of Virology

He was received by Chief Secretary Somesh Kumar, DGP M Mahender Reddy and three other officials on behalf of the State government.